Ratio of regurgitant fraction to aortic valve area for risk stratification of patients with mixed aortic valvular disease

European Heart Journal

5 November 2025
Organised by: Logo
ESC Journals

Abstract

AbstractBackground

In patients with mixed aortic valve disease (MAVD), defined as the combination of aortic stenosis (AS) and aortic regurgitation (AR), the assessment of the severity of each valve lesion is challenging, as most of the echocardiographic parameters tend to be inaccurate in this setting. Furthermore, limited and contradictory data exist regarding which measure of MAVD severity should be used to risk-stratify these patients. Aortic valve area (AVA), measured by the continuity equation, has shown to be reliable marker of AS severity in the presence of AR, while regurgitant fraction (RF), assessed using either the flow convergence or volumetric method, provides an accurate estimation of AR severity in the presence of AS.

Purpose

In this study including a large population of patients with significant MAVD, we evaluated the prognostic value of the ratio between RF to AVA, two of the most reliable measures for the assessment of AR and AS, respectively.

Methods

A total of 552 patients (mean age 66 ± 15 years, 58% male) with significant MAVD (≥ moderate AS and ≥moderate AR) were retrospectively analyzed. AVA was determined using the continuity equation, while LV stroke volume and aortic regurgitant volume were used to calculate the aortic RF. The RF/AVA ratio was defined as the aortic RF divided by the AVA. The study endpoint was all-cause mortality. Spline curve analysis was performed to identify the RF/AVA threshold associated with increased mortality.

Results

Over a median follow-up of 9 years (IQR, 3.6-14.4), 199 patients (36%) died. The cut-off of RF/AVA associated with increased mortality was ≥40 %/cm2 (Fig. 1). Patients with RF/AVA ≥40 were older (71±14 vs. 64±15 years, p<0.001) and less frequently male (51% vs. 63%, p=0.007). They also had larger left atrial volume index (LAVI 50±27 vs. 35±17 mL/m², p<0.001), higher prevalence of atrial fibrillation (36% vs. 22%, p=0.011), and more frequently LV and right ventricular dysfunction (LVEF<50%, 35% vs. 26%, p=0.025; TAPSE <18mm, 25% vs. 11%, p<0.001). However, both groups had a similar comorbidity profile. Survival rates at 1, 5, and 10 years were lower in patients with an RF/AVA ≥40 compared to those with an RF/AVA <40 (92% vs. 96%, 71% vs. 84%, and 56% vs. 71%, respectively; p<0.001) (Fig. 2). In univariate analysis, RF and AVA, when assessed separately, were not significantly associated with mortality (p=0.062 and p=0.059, respectively) as was peak aortic velocity (p=0.239). In turn, the RF/AVA ratio showed a significant association with mortality even after adjusting for relevant clinical and echocardiographic variables, including age, male sex, coronary artery disease, LVEF<50%, LAVI >34 ml/m2, TAPSE <18 mm, NYHA functional class II-IV, and aortic valve replacement as a time-dependent covariate (RF/AVA ≥40: HR 1.562, 95%CI 1.075-2.270; p=0.019).

Conclusion

The RF/AVA ratio may be a reliable tool to assess severity of MAVD and for risk stratifying these patients.

Contributors

M P Lopez Santi
M P Lopez Santi

Author

Leiden University Medical Center Leiden , Netherlands (The)

A P Chua
A P Chua

Author

J J Bax
J J Bax

Author